This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 1000+ CE and professional development courses.

Goals and Learning Outcomes

The latest statistics regarding the Human Immunodeficiency Virus (HIV) epidemic in the U.S. illustrate that there has been a decrease in the number of new HIV diagnoses from 2014 to 2018 by 7% (CDC, 2020). The Centers for Disease Control and Prevention (CDC) estimates 1.2 million people are living with HIV infection, and many do not know it. The good news is that with the use of antiretroviral therapies, the progression of HIV infection to Acquired Immunodeficiency Syndrome (AIDS) has been slowed, and AIDS deaths have been reduced. However, the bad news is that patients experience numerous difficulties taking these therapies, and adherence to treatment regimens can be challenging for patients. Healthcare providers can help design individualized plans of care to improve adherence. This activity will address barriers to adherence and negative consequences of nonadherence to drug therapy.

After taking this course, you should be able to:

  • Identify two important sequelae to medication nonadherence by patients with HIV
  • Identify two barriers and two facilitators to adherence to HIV medication regimens
  • List three critical components of interventions to promote adherence to HIV medications
  • Describe antiretroviral drug therapies and their impact on HIV/AIDS.
  • Identify important sequelae to medication nonadherence by patients with HIV.
  • Identify barriers and facilitators to adherence to HIV medication regimens.
  • List critical components of interventions to promote adherence to HIV medications.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/24

Course Originally Released On: 04/01/21

Course Authors

4.5 Average

Course Reviews

1523 reviews

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.